Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
9.04 ^USD	+1.57%		+0.11%	-2.80%

Mar. 06	Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating	MT
Feb. 21	Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating	MT

Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on July 30, 2013.

November 02, 2023 at 07:01 am EDT

From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 5,678,563 shares, representing 5.92% for $354.99 million under the buyback announced on July 30, 2013.

Latest news about Pediatrix Medical Group, Inc.

Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating	Mar. 06	MT
Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating	Feb. 21	MT
Mizuho Trims Price Target on Pediatrix Medical to $9 From $10, Maintains Neutral Rating	Feb. 21	MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $10 From $10.50, Keeps Hold Rating	Feb. 21	MT
US Equity Markets Decline Tuesday Ahead of FOMC Meeting Minutes	Feb. 20	MT
Pediatrix Medical Group Shares Fall After Q4 Adjusted Earnings, Revenue Decline	Feb. 20	MT
Pediatrix Medical Group, Inc. Provides Earnings Guidance for the Year 2024	Feb. 20	CI
Transcript : Pediatrix Medical Group, Inc., Q4 2023 Earnings Call, Feb 20, 2024	Feb. 20
North American Morning Briefing : Earnings Back in -2-	Feb. 20	DJ
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q4 Revenue $496.4M, vs. Street Est of $523.3M	Feb. 20	MT
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q4 EPS $0.32, vs. Street Est of $0.32	Feb. 20	MT
Pediatrix Medical Group, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 20	CI
UBS Initiates Coverage on Pediatrix Medical Group With Neutral Rating, $9.50 Price Target	Nov. 30	MT
Deutsche Bank Cuts Pediatrix Medical Price Target to $9 From $14, Maintains Sell Rating	Nov. 03	MT
Transcript : Pediatrix Medical Group, Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on August 2, 2018.	Nov. 02	CI
Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on July 30, 2013.	Nov. 02	CI
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q3 Revenue $506.6M, vs. Street Est of $508.3M	Nov. 02	MT
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q3 EPS $0.32, vs. Street Est of $0.43	Nov. 02	MT
Pediatrix Medical Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Transcript : Pediatrix Medical Group, Inc., Q2 2023 Earnings Call, Aug 03, 2023	23-08-03
Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on July 30, 2013.	23-08-03	CI
Tranche Update on Pediatrix Medical Group, Inc. (NYSE:MD)'s Equity Buyback Plan announced on August 2, 2018.	23-08-03	CI
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q2 Revenue $500.6M, vs. Street Est of $495.9M	23-08-03	MT
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q2 EPS $0.39, vs. Street Est of $0.40	23-08-03	MT

Chart Pediatrix Medical Group, Inc.

Duration

Period

More charts

Company Profile

Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Companyâs affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Sector

Healthcare Facilities & Services

Calendar

2024-05-07 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Pediatrix Medical Group, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

9.04 USD

Average target price

9.071 USD

Spread / Average Target

+0.35%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
PEDIATRIX MEDICAL GROUP, INC.	-2.80%	747M
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-3.06%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
PURE HEALTH HOLDING	-31.75%	11.77B
FRESENIUS MEDICAL CARE AG	-1.42%	11.72B
DAVITA INC.	+27.44%	11.71B

Other Healthcare Facilities & Services